| abstract |
The present invention relates to pharmaceutical compositions based on carrageenan as an active ingredient, for use as a medicament in the prophylactic or therapeutic treatment of allergic conditions or diseases, with the condition that carrageenan comprises iota and / or kappa-carrageenan and It is substantially free of lambda carrageenan. Typically, the invention relates to liquid formulations, gels and dry powder compositions which comprise iota and / or kappa carrageenan and, optionally, one or more non-carrageenan therapeutic agents, for administration to the respiratory tract, gastrointestinal tract or eyes. The compositions of the invention have been found to be effective in the prevention and treatment of type 1 allergies and additionally, they can exert an adjuvant function in mucosal administration combined with non-carrageenan therapeutic agents. |